MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

Exercise perceptions, behaviours and barriers (* = significant chi-squared test). by Jonathan Sinclair (5698898)

Exercise perceptions, behaviours and barriers (* = significant chi-squared test). by Jonathan Sinclair (5698898)

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)

Selection of final barriers based on significance. by Hasan Shahriar (5015273)

Subjects:

Pairwise comparison matrix of barriers’ significance. by Hasan Shahriar (5015273)

Subjects:

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. by Therese M. Gilligan (7460906)

Perceived barriers in providing cardiovascular diseases prevention services. by Farhana Fakhira Ismail (17060914)

Subjects:

Barriers to medication adherence. by Shiva Mohammadi (20227740)

Subjects:

HIBCPP barrier cultures significantly restrict JCPyV and EV^JC+. by Bethany A. O’Hara (8532741)

Barriers to providing education about the oral-systemic disease links to patients. by Fatimah Al-Habib (13989532)

Linguistic terms and corresponding triangular fuzzy scale for barrier significance assessment. by Hasan Shahriar (5015273)

Subjects:

The number of questions for which there were different levels of significance between the SES classes. by Sandra Parisi (8203119)

Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)

Barriers to DA. by Elizabeth Noble (4113616)

Subjects:

Significant quotes from themes related to barriers and facilitators to participating in peer support research and programs. by Stephanie K. C. Lau (11326453)

Bioengineering Approaches for the 3D Blood–Retinal Barrier: Disease Modeling and Drug Development by Ruiyi Yan (4594162)

“…In order to understand and recapitulate various retinal diseases, there has been significant interest in the progress of in vitro 3D-BRB models as they may address limitations associated with traditional 2D cultures and xenogeneic animal models. …”

Bioengineering Approaches for the 3D Blood–Retinal Barrier: Disease Modeling and Drug Development by Ruiyi Yan (4594162)

“…In order to understand and recapitulate various retinal diseases, there has been significant interest in the progress of in vitro 3D-BRB models as they may address limitations associated with traditional 2D cultures and xenogeneic animal models. …”